- Report
- December 2024
- 31 Pages
Germany
From €4406EUR$4,995USD£3,871GBP
- Report
- November 2024
- 750 Pages
Global
From €1764EUR$2,000USD£1,550GBP
- Report
- November 2024
- 750 Pages
Global
From €1764EUR$2,000USD£1,550GBP
- Report
- October 2024
- 216 Pages
Global
From €3528EUR$4,000USD£3,100GBP
- Report
- September 2024
- 117 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- May 2024
- 142 Pages
Global
From €3528EUR$4,000USD£3,100GBP
- Report
- January 2024
- 315 Pages
Global
From €2470EUR$2,800USD£2,170GBP
€3087EUR$3,500USD£2,712GBP
- Report
- January 2024
- 120 Pages
United States
€3087EUR$3,500USD£2,712GBP
- Report
- November 2023
- 190 Pages
Global
From €4366EUR$4,950USD£3,836GBP
- Report
- November 2023
- 110 Pages
Global
From €2602EUR$2,950USD£2,286GBP
- Report
- November 2023
- 109 Pages
Africa, Middle East
From €2602EUR$2,950USD£2,286GBP
- Report
- November 2023
- 107 Pages
From €2602EUR$2,950USD£2,286GBP
- Report
- November 2023
- 119 Pages
Asia Pacific
From €3043EUR$3,450USD£2,673GBP
- Report
- November 2023
- 122 Pages
Europe
From €3043EUR$3,450USD£2,673GBP
- Report
- November 2023
- 119 Pages
North America
From €2602EUR$2,950USD£2,286GBP
- Report
- March 2023
- 26 Pages
Global
€10805EUR$12,250USD£9,493GBP
- Report
- October 2021
- 180 Pages
United States
From €1764EUR$2,000USD£1,550GBP
€2205EUR$2,500USD£1,937GBP
- Report
- October 2021
- 70 Pages
United States
From €769EUR$872USD£676GBP
€961EUR$1,090USD£845GBP
- Report
- April 2021
- 85 Pages
United States
From €917EUR$1,039USD£805GBP
€1146EUR$1,299USD£1,007GBP
- Report
- March 2019
- 80 Pages
United States
From €910EUR$1,032USD£800GBP
€1138EUR$1,290USD£1,000GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more